1.
Urologiia
; (6): 17-9, 2001.
Article
in Russian
| MEDLINE
| ID: mdl-11785073
Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Agents, Hormonal/therapeutic use , Prostatic Neoplasms/drug therapy , Triptorelin Pamoate/therapeutic use , Adenocarcinoma/blood , Adenocarcinoma/secondary , Adenocarcinoma/surgery , Aged , Aged, 80 and over , Antineoplastic Agents, Hormonal/administration & dosage , Antineoplastic Agents, Hormonal/adverse effects , Bone Neoplasms/secondary , Humans , Injections, Intramuscular , Male , Middle Aged , Orchiectomy , Prostate-Specific Antigen/blood , Prostatic Neoplasms/blood , Prostatic Neoplasms/surgery , Testosterone/blood , Time Factors , Triptorelin Pamoate/administration & dosage , Triptorelin Pamoate/adverse effects
2.
Urol Nefrol (Mosk)
; (1): 13-5, 1988.
Article
in Russian
| MEDLINE
| ID: mdl-3363758